News & Updates
Filter by Specialty:
INCREASE OLE data reflect long-term benefit of inhaled treprostinil for PH-ILD
31 May 2022
byAudrey Abella
Findings from the open-label extension (OLE) phase of the INCREASE study boost the efficacy and safety of inhaled treprostinil for pulmonary hypertension due to interstitial lung disease (PH-ILD).